We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$76.2B
AUM Growth
+$1.88B
Cap. Flow
+$1.28B
Cap. Flow %
1.68%
Top 10 Hldgs %
13.88%
Holding
3,116
New
15
Increased
2,175
Reduced
498
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$71.6M
2
XOM icon
ExxonMobil
XOM
+$50.3M
3
CB icon
Chubb
CB
+$49M
4
META icon
Meta Platforms (Facebook)
META
+$45.4M
5
AVGO icon
Broadcom
AVGO
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Healthcare 13.64%
3 Financials 13.01%
4 Industrials 10.8%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OSBC icon
2776
Old Second Bancorp
OSBC
$1.29B
$299K ﹤0.01%
41,624
ARLZ
2777
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$299K ﹤0.01%
+84,100
New +$434K
HIFS icon
2778
Hingham Institution for Saving
HIFS
$627M
$298K ﹤0.01%
+2,496
New +$299K
WMAR
2779
DELISTED
West Marine Inc
WMAR
$298K ﹤0.01%
32,700
ADMS
2780
DELISTED
Adamas Pharmaceuticals
ADMS
$297K ﹤0.01%
20,472
+6,200
+43% +$104K
CTMX icon
2781
CytomX Therapeutics
CTMX
$675M
$296K ﹤0.01%
22,928
+357
+2% +$4.96K
KVHI icon
2782
KVH Industries
KVHI
$181M
$295K ﹤0.01%
30,800
PETX
2783
DELISTED
Aratana Therapeutics, Inc.
PETX
$295K ﹤0.01%
53,400
CVGI icon
2784
Commercial Vehicle Group
CVGI
$154M
$294K ﹤0.01%
110,588
+43,689
+65% +$114K
DXLG icon
2785
Destination XL Group
DXLG
$31.2M
$292K ﹤0.01%
56,400
OXFD
2786
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$292K ﹤0.01%
29,400
TPCO
2787
DELISTED
Tribune Publishing Company Common Stock
TPCO
$290K ﹤0.01%
37,517
+1,800
+5% +$14.5K
TLGT
2788
DELISTED
Teligent, Inc
TLGT
$289K ﹤0.01%
5,890
BRG
2789
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$287K ﹤0.01%
26,308
-11,400
-30% -$119K
HBIO icon
2790
Harvard Bioscience
HBIO
$27.5M
$285K ﹤0.01%
9,423
USLM icon
2791
United States Lime & Minerals
USLM
$3.16B
$285K ﹤0.01%
23,670
+255
+1% +$2.76K
RELY
2792
DELISTED
Real Industry, Inc.
RELY
$285K ﹤0.01%
32,714
INST
2793
DELISTED
Instructure, Inc.
INST
$283K ﹤0.01%
15,752
+255
+2% +$4.39K
GNRT
2794
DELISTED
Gener8 Maritime, Inc.
GNRT
$283K ﹤0.01%
39,955
+816
+2% +$5.27K
ARDX icon
2795
Ardelyx
ARDX
$1.22B
$282K ﹤0.01%
36,240
+12,300
+51% +$121K
TARO
2796
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$281K ﹤0.01%
1,960
KDNY
2797
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$281K ﹤0.01%
4,387
+82
+2% +$6.63K
DCO icon
2798
Ducommun
DCO
$2.7B
$280K ﹤0.01%
18,300
SYUT
2799
DELISTED
Synutra International, Inc.
SYUT
$280K ﹤0.01%
56,274
+1,377
+3% +$6.7K
AMRC icon
2800
Ameresco
AMRC
$1.12B
$277K ﹤0.01%
57,882
+1,256
+2% +$6.4K

Similar funds

Charles Schwab's Q1 2016 Portfolio in Review

As of Q1 2016, Charles Schwab held 3,116 positions worth $76.2B, up 2.5% from $74.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.2%. Charles Schwab opened 15 new positions and exited 54, leaving the 3,116-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q1 2016 buy was Tailored Brands, Inc.: 313,726 shares worth $5.62M.
  • Charles Schwab added most to Merck in Q1 2016, an estimated $71.6M increase.
  • Charles Schwab's biggest Q1 2016 reduction was Home Depot, cutting an estimated $111M.
  • Charles Schwab fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $87.3M.
  • Charles Schwab's ten largest holdings make up 14% of its $76.2B portfolio in Q1 2016.
  • Charles Schwab opened 15 new positions and closed 54 in Q1 2016.
  • Charles Schwab's portfolio value rose 2.5% quarter-over-quarter to $76.2B.

Based on Charles Schwab's 13F filing for Q1 2016, filed 5 May 2016.